U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07257289) titled 'Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease' on Nov. 20.

Brief Summary: Sudden cardiac death (SCD) is one of the leading causes of death in developed countries. These deaths (more than 5,000 per year in France) are due to hereditary arrhythmias or cardiomyopathies. Early diagnosis of SCD is often achieved through family screening, but the main challenge is to stratify the risk of SCD in these patients. Indeed, prevention of SCD relies mainly on the implantation of an automatic defibrillator. The challenge is to identify patients who will develop SCD and avoid implanting an imp...